Clinical evaluation and prevalence of fibromyalgia in hepatitis C patients

Detalhes bibliográficos
Autor(a) principal: Garcia,João Batista Santos
Data de Publicação: 2019
Outros Autores: Moura,Silvia Amália de Melo, Kraychete,Durval Campos, Castro,Anita Perpetua Carvalho Rocha, Garcia,Marilia Arrais
Tipo de documento: Artigo
Idioma: eng
Título da fonte: BrJP (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922019000400308
Resumo: ABSTRACT BACKGROUND AND OBJECTIVES: The worldwide distribution and etiology of fibromyalgia are poorly understood. It is believed that different factors are involved, such as hepatitis C virus infection. The aim of this study was to estimate the prevalence of fibromyalgia in hepatitis C virus infected patients, trying to identify the occurrence of liver injury, extrahepatic clinical manifestations, anxiety, depression, and the impact on the quality of life. METHODS: This is a cross-sectional study of patients (n=118) with hepatitis C virus infection who were compared with a group of clinically stable patients not infected with the hepatitis C virus (n=118). The Anxiety and Depression Questionnaire was applied, and for those diagnosed with fibromyalgia, the Fibromyalgia Impact Questionnaire. Liver biopsies were analyzed according to the METAVIR classification. The Schirmer test was performed to investigate abnormal tear production in the studied patients. Data analysis was performed using the Statistical Package for Social Sciences (SPSS) software, v.10.0. RESULTS: The prevalence of fibromyalgia in infected patients was 7.6%. In patients infected with fibromyalgia, a significant prevalence of anxiety and depression was observed. Fibromyalgia Impact Questionnaire scores were higher in infected patients with fibromyalgia. When comparing the complementary tests in infected patients with and without fibromyalgia, no significant differences were found for the Schirmer test, viral genotype, and degree of fibrosis and liver inflammation. CONCLUSION: In females, there was a positive relationship between hepatitis C virus infection, fibromyalgia, and extrahepatic symptoms, which translates into a higher prevalence of anxiety and depression and impaired quality of life.
id SBED-2_5cf7efbed901536c551475b4e10c5355
oai_identifier_str oai:scielo:S2595-31922019000400308
network_acronym_str SBED-2
network_name_str BrJP (Online)
repository_id_str
spelling Clinical evaluation and prevalence of fibromyalgia in hepatitis C patientsChronic painFibromyalgiaHepatitis CABSTRACT BACKGROUND AND OBJECTIVES: The worldwide distribution and etiology of fibromyalgia are poorly understood. It is believed that different factors are involved, such as hepatitis C virus infection. The aim of this study was to estimate the prevalence of fibromyalgia in hepatitis C virus infected patients, trying to identify the occurrence of liver injury, extrahepatic clinical manifestations, anxiety, depression, and the impact on the quality of life. METHODS: This is a cross-sectional study of patients (n=118) with hepatitis C virus infection who were compared with a group of clinically stable patients not infected with the hepatitis C virus (n=118). The Anxiety and Depression Questionnaire was applied, and for those diagnosed with fibromyalgia, the Fibromyalgia Impact Questionnaire. Liver biopsies were analyzed according to the METAVIR classification. The Schirmer test was performed to investigate abnormal tear production in the studied patients. Data analysis was performed using the Statistical Package for Social Sciences (SPSS) software, v.10.0. RESULTS: The prevalence of fibromyalgia in infected patients was 7.6%. In patients infected with fibromyalgia, a significant prevalence of anxiety and depression was observed. Fibromyalgia Impact Questionnaire scores were higher in infected patients with fibromyalgia. When comparing the complementary tests in infected patients with and without fibromyalgia, no significant differences were found for the Schirmer test, viral genotype, and degree of fibrosis and liver inflammation. CONCLUSION: In females, there was a positive relationship between hepatitis C virus infection, fibromyalgia, and extrahepatic symptoms, which translates into a higher prevalence of anxiety and depression and impaired quality of life.Sociedade Brasileira para o Estudo da Dor2019-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922019000400308BrJP v.2 n.4 2019reponame:BrJP (Online)instname:Sociedade Brasileira para o Estudo da Dor (SBED)instacron:SBED10.5935/2595-0118.20190057info:eu-repo/semantics/openAccessGarcia,João Batista SantosMoura,Silvia Amália de MeloKraychete,Durval CamposCastro,Anita Perpetua Carvalho RochaGarcia,Marilia Arraiseng2019-11-29T00:00:00Zoai:scielo:S2595-31922019000400308Revistahttps://sbed.org.br/publicacoes-publicacoes-bjp/ONGhttps://old.scielo.br/oai/scielo-oai.phpdkt@terra.com.br || dor@dor.org.br2595-31922595-0118opendoar:2019-11-29T00:00BrJP (Online) - Sociedade Brasileira para o Estudo da Dor (SBED)false
dc.title.none.fl_str_mv Clinical evaluation and prevalence of fibromyalgia in hepatitis C patients
title Clinical evaluation and prevalence of fibromyalgia in hepatitis C patients
spellingShingle Clinical evaluation and prevalence of fibromyalgia in hepatitis C patients
Garcia,João Batista Santos
Chronic pain
Fibromyalgia
Hepatitis C
title_short Clinical evaluation and prevalence of fibromyalgia in hepatitis C patients
title_full Clinical evaluation and prevalence of fibromyalgia in hepatitis C patients
title_fullStr Clinical evaluation and prevalence of fibromyalgia in hepatitis C patients
title_full_unstemmed Clinical evaluation and prevalence of fibromyalgia in hepatitis C patients
title_sort Clinical evaluation and prevalence of fibromyalgia in hepatitis C patients
author Garcia,João Batista Santos
author_facet Garcia,João Batista Santos
Moura,Silvia Amália de Melo
Kraychete,Durval Campos
Castro,Anita Perpetua Carvalho Rocha
Garcia,Marilia Arrais
author_role author
author2 Moura,Silvia Amália de Melo
Kraychete,Durval Campos
Castro,Anita Perpetua Carvalho Rocha
Garcia,Marilia Arrais
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Garcia,João Batista Santos
Moura,Silvia Amália de Melo
Kraychete,Durval Campos
Castro,Anita Perpetua Carvalho Rocha
Garcia,Marilia Arrais
dc.subject.por.fl_str_mv Chronic pain
Fibromyalgia
Hepatitis C
topic Chronic pain
Fibromyalgia
Hepatitis C
description ABSTRACT BACKGROUND AND OBJECTIVES: The worldwide distribution and etiology of fibromyalgia are poorly understood. It is believed that different factors are involved, such as hepatitis C virus infection. The aim of this study was to estimate the prevalence of fibromyalgia in hepatitis C virus infected patients, trying to identify the occurrence of liver injury, extrahepatic clinical manifestations, anxiety, depression, and the impact on the quality of life. METHODS: This is a cross-sectional study of patients (n=118) with hepatitis C virus infection who were compared with a group of clinically stable patients not infected with the hepatitis C virus (n=118). The Anxiety and Depression Questionnaire was applied, and for those diagnosed with fibromyalgia, the Fibromyalgia Impact Questionnaire. Liver biopsies were analyzed according to the METAVIR classification. The Schirmer test was performed to investigate abnormal tear production in the studied patients. Data analysis was performed using the Statistical Package for Social Sciences (SPSS) software, v.10.0. RESULTS: The prevalence of fibromyalgia in infected patients was 7.6%. In patients infected with fibromyalgia, a significant prevalence of anxiety and depression was observed. Fibromyalgia Impact Questionnaire scores were higher in infected patients with fibromyalgia. When comparing the complementary tests in infected patients with and without fibromyalgia, no significant differences were found for the Schirmer test, viral genotype, and degree of fibrosis and liver inflammation. CONCLUSION: In females, there was a positive relationship between hepatitis C virus infection, fibromyalgia, and extrahepatic symptoms, which translates into a higher prevalence of anxiety and depression and impaired quality of life.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922019000400308
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922019000400308
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/2595-0118.20190057
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
dc.source.none.fl_str_mv BrJP v.2 n.4 2019
reponame:BrJP (Online)
instname:Sociedade Brasileira para o Estudo da Dor (SBED)
instacron:SBED
instname_str Sociedade Brasileira para o Estudo da Dor (SBED)
instacron_str SBED
institution SBED
reponame_str BrJP (Online)
collection BrJP (Online)
repository.name.fl_str_mv BrJP (Online) - Sociedade Brasileira para o Estudo da Dor (SBED)
repository.mail.fl_str_mv dkt@terra.com.br || dor@dor.org.br
_version_ 1754732509880385536